---

Easy to use and up to date, this second edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the prevention of thromboembolic disorders and the protection of the vascular endothelium.

---

During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic. Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition provides updates on various strategies in thrombosis, experimental models, and clinical and recent advances in the discovery and development of novel antithrombotics. As a volume in the highly successful Methods in Molecular Biology(TM) series, this collection provides the kind of detailed description and implementation advice that is crucial for getting optimal results.

Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the prevention of thromboembolic disorders and the protection of the vascular endothelium.

---

1. In vitro Methods of Evaluating Antithrombotics and Thrombolytics
Shaker A. Mousa

2. In vivo Models for the Evaluation of Antithrombotics and Thrombolytics
Shaker A. Mousa

3. Heparin and Low Molecular Weight Heparins in Thrombosis and Beyond
Shaker A. Mousa

4. Laboratory Methods and Management of Patients with Heparin-Induced Thrombocytopenia
Margaret Prechel, Walter P. Jeske, and Jeanine M. Walenga

5. Novel Anticoagulant Therapy: Principle and Practice
Shaker A. Mousa

6. Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban
Shaker A. Mousa

7. Antiplatelet Therapies: Drug Interactions in the Management of Vascular Disorders
Shaker A. Mousa

8. Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
Shaker A. Mousa, Walter P. Jeske, and Jawed Fareed

9. Antithrombotic Effects of Naturally Derived Products on Coagulation and Platelet Function
Shaker A. Mousa

10. Assessment of Anti-Metastatic Effects of Anticoagulant and Antiplatelet Agents Using Animal Models of Experimental Lung Metastasis
Ali Amirkhosravi, Shaker A. Mousa, Mildred Amaya, Todd Meyer, Monica Davila, Theresa Robson, and John L. Francis

11. Adhesion Molecules: Potential Therapeutic & Diagnostic Implications
Shaker A. Mousa

12. Pharmacogenomics in Thrombosis
Shaker A. Mousa

13. Diagnosis and Management of Sickle Cell Disorders
Shaker A. Mousa and Mohamad H. Qari

---